Canada· CA-DIN-02532573
CAMZYOS
A mavacamten product containing mavacamten, registered in Canada by BRISTOL-MYERS SQUIBB CANADA. The same ATC class is registered in 15 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Mavacamten is registered in 15 of 19 countries.
Countries holding a registration under ATC C01EB24 (mavacamten), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Mavacamten · ATC C01EB24
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mavacamten costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mavacamten · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$118.52
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- MAVACAMTEN
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Country
- Canada (CA)
- ATC code
- C01EB24
- ATC class
- Mavacamten
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mavacamten in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCAMZYOSBristol-Myers Squibb Pharma EEIG, Dublin
- SwitzerlandCamzyos
- SpainCAMZYOS 15 MG CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- FinlandCAMZYOSBristol-Myers Squibb Pharma EEIG
- FranceCAMZYOS 15 mg, géluleBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- United KingdomCamzyos 15mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- IrelandCamzyos 15 mg Capsule hardBristol-Myers Squibb Pharma EEIG
- IcelandCamzyosBristol-Myers Squibb Pharma EEIG*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Camzyos
- Liechtenstein · Camzyos
- Norway · Camzyos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0eb6b867-102c-47b9-bf61-ebde778be410 GET /v1/drugs/0eb6b867-102c-47b9-bf61-ebde778be410?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02532573",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C01EB24",
"schedule": [
"Prescription"
],
"drug_code": "102160",
"strengths": [
"15 MG"
],
"ahfs_class": null,
"substances": [
"MAVACAMTEN"
],
"product_categorization": null
}See everything about mavacamten.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.